MAPT and Alzheimer disease: It was reported that brain insulin resistance or brain insulin reduction can accelerate AD pathologies such as neurofibrillary tangles and Aβ deposition [32], mainly mediated by insulin-like growth-factor (IGF) signaling, which can regulate the expression of tau protein and its phosphorylation [32].